Gilead Sciences Completes Purchase of YM BioSciences
Gilead Sciences Inc., a biopharmaceuticals company based in Foster City, California, has closed its acquisition of all of the outstanding common shares of YM BioSciences Inc., a drug development company that has focused on treatments for blood and immune cell disorders. The transaction, which was originally announced in December, has been priced at around US$510 million. The Mississauga, Ontario-based YM Biosciences was founded in the mid-1990s with the backing of Canadian venture capital firm Covington Funds.
11 February 2013•2 mins read
